INSP DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Inspire Medical Systems Investors Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Inspire Medical Systems, Inc. due to allegations of misleading statements regarding the launch of its Inspire V device, which has faced significant setbacks and weak demand [2][4]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in Inspire Medical to contact them to discuss their legal options [1]. - A federal securities class action has been filed against Inspire Medical, with a deadline of January 5, 2026, for investors to seek the role of lead plaintiff [2][7]. Group 2: Company Performance and Issues - Inspire Medical announced on August 4, 2025, that the launch of its Inspire V device was delayed due to treatment centers not completing necessary training and onboarding [5]. - The company faced billing and reimbursement challenges, as Medicare's approval of a CPT code for Inspire V did not coincide with the necessary software updates for claims processing [5]. - Inspire Medical reported weak demand and excess inventory for the Inspire V device, leading to a more than 80% cut in its 2025 earnings guidance [6]. Group 3: Market Impact - Following the announcement of setbacks, Inspire Medical's stock price plummeted over 32% in one day, from $129.95 to $87.91, resulting in a loss of approximately $1.2 billion in market capitalization [6].